VERISIGN INC/CA
For the period ended Dec 31, 2025. Filed Feb 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 5, 2026
VRSN$311.12+1.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net income | $825.7 | $785.7 | $817.6 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation of property and equipment | 31.2 | 36.9 | 44.1 |
| Stock-based compensation expense | 69.7 | 61.1 | 59.7 |
| Amortization of discount on investments in debt securities | (11.6) | (21.1) | (27.8) |
| Other, net | 6.5 | 3.6 | 3.3 |
| Changes in operating assets and liabilities: | |||
| Other assets | (1.4) | (12.4) | (1.5) |
| Other liabilities | 42.7 | (28.9) | (2.2) |
| Deferred revenues | 80.2 | 58.1 | 27.0 |
| Net deferred income taxes | 48.1 | 19.6 | (66.4) |
| Net cash provided by operating activities | 1,091.1 | 902.6 | 853.8 |
| Cash flows from investing activities: | |||
| Proceeds from maturities and sales of marketable securities | 704.3 | 1,195.1 | 1,278.9 |
| Purchases of marketable securities | (572.2) | (880.7) | (1,330.5) |
| Purchases of property and equipment | (22.8) | (28.1) | (45.8) |
| Other investing activities | (0.2) | — | — |
| Net cash provided by (used in) investing activities | 109.1 | 286.3 | (97.4) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (881.6) | (1,225.6) | (901.4) |
| Repayment of borrowings | (500.0) | — | — |
| Proceeds from senior note issuance, net of issuance costs | 493.3 | — | — |
| Payment of dividends | (215.2) | — | — |
| Proceeds from employee stock purchase plan | 12.3 | 12.3 | 12.3 |
| Payment of excise tax on repurchases of common stock | (11.6) | (8.2) | — |
| Other financing activities | — | — | (0.7) |
| Net cash used in financing activities | (1,102.8) | (1,221.5) | (889.8) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | — | (0.8) | (0.1) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 97.4 | (33.4) | (133.5) |
| Cash, cash equivalents, and restricted cash at beginning of period | 212.1 | 245.5 | 379.0 |
| Cash, cash equivalents, and restricted cash at end of period | $309.5 | $212.1 | $245.5 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.